DABIGATRAN – THE NEW APPROACH FOR DEEP VENOUS TROMBOSIS PROPHYLAXIS

Travmatologiâ i Ortopediâ Rossii

T. B. Minasov¹  B. Sh. Minasov¹  N. Sh. Zagidullin¹  Sh. Z. Zagidullin¹  N. Gassanov²  E. Caglayan² 

[1] ГБОУ ВПО «Башкирский государственный медицинский университет Росздрава», г. Уфа;Университетская клиника внутренних болезней, г. Кёльн;

关键词: joint replacement;    deep venous trombosis;    anticoagulants;    dabigatran;   

DOI  :  10.21823/2311-2905-2011-0-3-80-83

来源: DOAJ

【 摘 要 】

The amount of total joint replacement is more than 1.5 mln world wide and requirement is increasing each year. Nevertheless one of the most dramatic complication after orthopedic manipulations are deep venous trombosis. As known, two aspects of prophylaxis are most important: duration of treatment and the doses of drags. The aim of study was to analys the influence of dabigatran for the risk of postop complications with the short time patients treatment complains. Treatment combination with dabigatran was clinically effective and the rate of adversing events was low. Thus we can conclude that treatment complains of dabigatran significantly higher then traditional injections of low molecular weight heparins.

【 授权许可】

Unknown